Search Results - "Chrétien, Marie‐Lorraine"

Early achievement of measurable residual disease negativity in the treatment of multiple myeloma as predictor of outcome by Baumelou, Marion, Payssot, Alexandre, Row, Celine, Racine, Jessica, Lafon, Ingrid, Bastie, Jean‐Noél, Chevreux, Steeve, Chrétien, Marie‐Lorraine, Maynadié, Marc, Caillot, Denis, Guy, Julien

Get full text

Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study by Heiblig, Maël, Rea, Delphine, Chrétien, Marie-Lorraine, Charbonnier, Aude, Rousselot, Philippe, Coiteux, Valérie, Escoffre-Barbe, Martine, Dubruille, Viviane, Huguet, Françoise, Cayssials, Emilie, Hermet, Eric, Guerci-Bresler, Agnès, Amé, Shanti, Sackmann-Sala, Lucila, Roy, Lydia, Sobh, Mohamad, Morisset, Stéphane, Etienne, Gabriel, Nicolini, Franck E.

“…•We report the use of ponatinib in chronic myelogenous leukemia (CML) patients who failed at least two lines of tyrosine kinase inhibitors (TKI) in a real-life…”
Get full text

Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma by Dejoie, Thomas, Corre, Jill, Caillon, Helene, Hulin, Cyrille, Perrot, Aurore, Caillot, Denis, Boyle, Eileen, Chretien, Marie-Lorraine, Fontan, Jean, Belhadj, Karim, Brechignac, Sabine, Decaux, Olivier, Voillat, Laurent, Rodon, Philippe, Fitoussi, Olivier, Araujo, Carla, Benboubker, Lotfi, Fontan, Charlotte, Tiab, Mourad, Godmer, Pascal, Luycx, Odile, Allangba, Olivier, Pignon, Jean-Michel, Fuzibet, Jean-Gabriel, Legros, Laurence, Stoppa, Anne Marie, Dib, Mamoun, Pegourie, Brigitte, Orsini-Piocelle, Frederique, Karlin, Lionel, Arnulf, Bertrand, Roussel, Murielle, Garderet, Laurent, Mohty, Mohamad, Meuleman, Nathalie, Doyen, Chantal, Lenain, Pascal, Macro, Margaret, Leleu, Xavier, Facon, Thierry, Moreau, Philippe, Attal, Michel, Avet-Loiseau, Herve

“…Guidelines for monitoring multiple myeloma (MM) patients expressing light chains only (light-chain MM [LCMM]) rely on measurements of monoclonal protein in…”
Get full text

Cost and efficacy of peripheral stem cell mobilization strategies in multiple myeloma by Van de Wyngaert, Zoé, Nerich, Virginie, Fouquet, Guillemette, Chrétien, Marie-Lorraine, Caillot, Denis, Azar, Nabih, Garderet, Laurent, Lenain, Pascal, Macro, Margaret, Bourhis, Jean-Henri, Belhocine, Ramdane, Jaccard, Arnaud, Karlin, Lionel, Bobin, Arthur, Moya, Niels, Systchenko, Thomas, Gruchet, Cecile, Giraud, Christine, Guidez, Stéphanie, Darras, Claire, Princet, Isabelle, Touzeau, Cyrille, Moreau, Philippe, Hulin, Cyrille, Deconinck, Erik, Limat, Samuel, Leleu, Xavier

“…Mobilization of peripheral blood stem cells (PBSC) can be performed using plerixafor, which is expensive, or high-dose cyclophosphamide (HDCy). We hypothesized…”
Get full text

Nosocomial Infections with IMP-19-Producing Pseudomonas aeruginosa Linked to Contaminated Sinks, France by Amoureux, Lucie, Riedweg, Karena, Chapuis, Angélique, Bador, Julien, Siebor, Eliane, Péchinot, André, Chrétien, Marie-Lorraine, de Curraize, Claire, Neuwirth, Catherine

“…We isolated IMP-19-producing Pseudomonas aeruginosa from 7 patients with nosocomial infections linked to contaminated sinks in France. We showed that bla was…”
Get full text

Extending autologous transplantation as first line therapy in multiple myeloma patients with severe renal impairment: a retrospective study by the SFGM-TC by Augeul-Meunier, Karine, Chretien, Marie-Lorraine, Stoppa, Anne-Marie, Karlin, Lionel, Benboubker, Lofti, Diaz, Jose Miguel Torregrosa, Mohty, Mohamad, Yakoub-Agha, Ibrahim, Bay, Jacques-Olivier, Perrot, Aurore, Bulabois, Claude-Eric, Huynh, Anne, Mercier, Mélanie, Frenzel, Laurent, Avet-Loiseau, Hervé, de Latour, Régis Peffault, Cornillon, Jérôme

“…Renal impairment is a common complication of multiple myeloma (MM), accounting for 20–30% of MM patients at diagnosis and 40–50% of patients during the course…”
Get full text

HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis by Sevin, Margaux, Kubovcakova, Lucia, Pernet, Nicolas, Causse, Sébastien, Vitte, Franck, Villeval, Jean Luc, Lacout, Catherine, Cordonnier, Marine, Rodrigues-Lima, Fernando, Chanteloup, Gaétan, Mosca, Matthieu, Chrétien, Marie-Lorraine, Bastie, Jean Noël, Audia, Sylvain, Sagot, Paul, Ramla, Selim, Martin, Laurent, Gleave, Martin, Mezger, Valérie, Skoda, Radek, Plo, Isabelle, Garrido, Carmen, Girodon, François, de Thonel, Aurélie

“…Heat shock protein 27 (HSP27/HSPB1) is a stress-inducible chaperone that facilitates cancer development by its proliferative and anti-apoptotic functions. The…”
Get full text

Antibody–Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review by Rossi, Cédric, Chrétien, Marie-Lorraine, Casasnovas, René-Olivier

“…Antibody–drug conjugates (ADCs) are an emerging class of therapeutic agents that bring new opportunities for the treatment of hematological malignancies by…”
Get full text

Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow by Mazzotti, Céline, Buisson, Laure, Maheo, Sabrina, Perrot, Aurore, Chretien, Marie-Lorraine, Leleu, Xavier, Hulin, Cyrille, Manier, Salomon, Hébraud, Benjamin, Roussel, Murielle, Do Souto, Laura, Attal, Michel, Avet-Loiseau, Hervé, Corre, Jill

“…•There is no correlation between ctDNA and bone marrow for MRD by NGS using only immunoglobulin gene rearrangements in myeloma patients…”
Get full text

Outbreak of Extended-Spectrum Beta-Lactamase Producing Enterobacter cloacae with High MICs of Quaternary Ammonium Compounds in a Hematology Ward Associated with Contaminated Sinks by Chapuis, Angélique, Amoureux, Lucie, Bador, Julien, Gavalas, Arthur, Siebor, Eliane, Chrétien, Marie-Lorraine, Caillot, Denis, Janin, Marion, de Curraize, Claire, Neuwirth, Catherine

“…To investigate an outbreak of extended-spectrum beta-lactamase (ESBL) producing Enterobacter cloacae that occurred in the Hematology ward (24-bed unit) of the…”
Get full text

Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment by Nakamura, Kyohei, Kassem, Sahar, Cleynen, Alice, Chrétien, Marie-Lorraine, Guillerey, Camille, Putz, Eva Maria, Bald, Tobias, Förster, Irmgard, Vuckovic, Slavica, Hill, Geoffrey R., Masters, Seth L., Chesi, Marta, Bergsagel, P. Leif, Avet-Loiseau, Hervé, Martinet, Ludovic, Smyth, Mark J.

“…Tumor-promoting inflammation and avoiding immune destruction are hallmarks of cancer. Here, we demonstrate that the pro-inflammatory cytokine interleukin…”
Get full text

Carfilzomib Weekly plus Melphalan and Prednisone in Newly Diagnosed Transplant-Ineligible Multiple Myeloma (IFM 2012-03): A Phase I Trial by Leleu, Xavier, Fouquet, Guillemette, Richez, Valentine, Guidez, Stéphanie, Duhamel, Alain, Machuron, François, Karlin, Lionel, Kolb, Brigitte, Tiab, Mourad, Araujo, Carla, Meuleman, Nathalie, Malfuson, Jean-Valère, Bourquard, Pascal, Lenain, Pascal, Roussel, Murielle, Jaccard, Arnaud, Pétillon, Marie-Odile, Belhadj-Merzoug, Karim, Lepeu, Gérard, Chrétien, Marie-Lorraine, Fontan, Jean, Rodon, Philippe, Schmitt, Anna, Offner, Fritz, Voillat, Laurent, Cereja, Sophie, Kuhnowski, Frédérique, Rigaudeau, Sophie, Decaux, Olivier, Humbrecht-Kraut, Catherine, Frayfer, Jamile, Fitoussi, Olivier, Roos-Weil, Damien, Eisenmann, Jean-Claude, Dorvaux, Véronique, Voog, Eric G, Attal, Michel, Moreau, Philippe, Avet-Loiseau, Hervé, Hulin, Cyrille, Facon, Thierry

“…Carfilzomib is a novel generation proteasome inhibitor. The Carmysap trial demonstrated that twice-weekly KMP (carfilzomib, melphalan, prednisone) might…”
Get full text

BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) by Cornillon, Jérôme, Daguenet, Elisabeth, Bay, Jacques-Olivier, Chauchet, Adrien, Salles, Gilles, Contentin, Nathalie, Nicolas-Virelizier, Emmanuelle, Mercier, Mélanie, Vallet, Nicolas, Alexis, Magda, Chrétien, Marie-Lorraine, Cluzeau, Thomas, Huynh, Anne, Himberlin, Chantal, Dorvaux, Véronique, Amorim, Sandy, Lejeune, Caroline, de Latour, Régis Peffault, Gyan, Emmanuel

“…High-dose chemotherapy before autologous transplantation is a therapeutic option as consolidation in primary or relapsed lymphoma. Even if BEAM conditioning is…”
Get full text

CD45 phosphatase is crucial for human and murine acute myeloid leukemia maintenance through its localization in lipid rafts by Saint-Paul, Laetitia, Nguyen, Chi-Hung, Buffière, Anne, Pais de Barros, Jean-Paul, Hammann, Arlette, Landras-Guetta, Corinne, Filomenko, Rodolphe, Chrétien, Marie-Lorraine, Johnson, Pauline, Bastie, Jean-Noël, Delva, Laurent, Quéré, Ronan

“…CD45 is a pan-leukocyte protein with tyrosine phosphatase activity involved in the regulation of signal transduction in hematopoiesis. Exploiting CD45 KO mice…”
Get full text

Trim33/Tif1γ is involved in late stages of granulomonopoiesis in mice by Chrétien, Marie-Lorraine, Legougea, Caroline, Martin, Romain Z, Hammann, Arlette, Trad, Malika, Aucagne, Romain, Largeot, Anne, Bastiea, Jean-Noël, Delva, Laurent, Quéré, Ronan

“…Trim33/Tif1γ (Trim33) is a member of the tripartite motif family. Using a conditional hematopoietic-specific Trim33 knock-out (Trim33Δ/Δ ) mouse, we showed…”
Get full text

Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21) by Burlet, Bénédicte, Ramla, Selim, Fournier, Cyril, Abrey-Recalde, Maria Jimena, Sauter, Camille, Chrétien, Marie-Lorraine, Rossi, Cédric, Duffourd, Yannis, Ragot, Sylviane, Buriller, Céline, Tournier, Benjamin, Chapusot, Caroline, Nadal, Nathalie, Racine, Jessica, Guy, Julien, Bailly, François, Martin, Laurent, Casasnovas, Olivier, Bastie, Jean-Noël, Caillot, Denis, Albuisson, Juliette, Broccardo, Cyril, Thieblemont, Catherine, Delva, Laurent, Maynadié, Marc, Aucagne, Romain, Callanan, Mary B

“…Diagnosis of B-cell chronic lymphocytic leukemia (B-CLL) is usually straightforward, involving clinical, immunophenotypic (Matutes score), and (immuno)genetic…”
Get full text

Nosocomial Infections with IMP-19−Producing Pseudomonas aeruginosa Linked to Contaminated Sinks, France by Amoureux, Lucie, Riedweg, Karena, Chapuis, Angélique, Bador, Julien, Siebor, Eliane, Péchinot, André, Chrétien, Marie-Lorraine, de Curraize, Claire, Neuwirth, Catherine

Get full text

Adherence to immunomodulatory drugs in patients with multiple myeloma by Cransac, Amélie, Aho, Serge, Chretien, Marie-Lorraine, Giroud, Maurice, Caillot, Denis, Boulin, Mathieu

“…Immunomodulatory drugs (thalidomide, lenalidomide and pomalidomide; IMID) are widely used in the treatment of multiple myeloma patients. To date, few data are…”
Get full text

Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: IFM 2020-04 study by Talbot, Alexis, Bobin, Arthur, Tabone, Léa, Lambert, Jérôme, Boccaccio, Catherine, Deal, Cécile, Petillon, Marie-Odile, Allangba, Olivier, Agape, Philippe, Arnautou, Pierre, Belkhir, Rakiba, Cailleres, Sylvie, Chaoui, Driss, Chrétien, Marie-Lorraine, Decaux, Olivier, Schulmann, Samantha, Frenzel, Laurent, Gastaud, Lauris, Huart, Antoine, Hulin, Cyrille, Karlin, Lionel, Laribi, Kamel, Le Calloch, Ronan, Lenain, Pascal, Macro, Margaret, Manier, Salomon, Montes, Lydia, Moreau, Stéphane, Moreau, Philippe, Morel, Véronique, Norwood, James, Piocelle, Frédérique Orsini, Perrot, Aurore, Pica, Gian Matteo, Rey, Philippe, Schmitt, Anna, Stoppa, Anne-Marie, Tiab, Mourad, Touzeau, Cyrille, Vidal, Valérie, Vignon, Marguerite, Vincent, Laure, Van De Wyngaert, Zoé, Zarnitsky, Charles, Kerbouche, Naima, Paka, Prani, Leleu, Xavier, Arnulf, Bertrand, Avet-Loiseau, Hervé

“…Belantamab mafodotin (BM) is an anti-BCMA antibody-drug conjugate (GSK2857916) that represents an alternative option in multiple myeloma. We sought to assess…”
Get full text

Efficacy, safety, and cost of pomalidomide in relapsed and refractory multiple myeloma by Gueneau, Pauline, Chretien, Marie‐Lorraine, Cransac‐Miet, Amelie, Aho, Ludwig Serge, Lafon, Ingrid, Favennec, Camille, Guy, Julien, Caillot, Denis, Boulin, Mathieu

“…Objectives To investigate the efficacy, safety, and cost of a pomalidomide‐dexamethasone regimen in patients with relapsed and refractory multiple myeloma…”
Get full text